N@N

ORTHOVITA INC (NASDAQ:VITA), Up By 31.92% ($0.68) From $2.130 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullis

^{Published on 2011-05-11 07:54:37 - WOPRAI}
 

May 10, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Wednesday, April 20th 2011 stating that ORTHOVITA INC (NASDAQ:VITA) was expected to go Up due to the Bullish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=vita&id=161904

At the time this story was written, ORTHOVITA INC (NASDAQ:VITA) is Up By $0.68 (31.92%) since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.

The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

ORTHOVITA INC (NASDAQ:VITA) - Orthovita, Inc., a specialty spine and orthopedic company, develops and markets orthobiologic and biosurgery products. The companys orthobiologics platform offers products for the fusion, regeneration, and fixation of human bone; and the biosurgery platform provides products for controlling intra-operative bleeding/hemostasis. Its orthobiologic product portfolio comprises Vitoss bone graft substitute, a high-porous resorbable beta-tricalcium phosphate bone graft substitute used to help the body guide the three-dimensional regeneration of the patients own bone; Bone Marrow Aspiration System with imbibe needles, syringes, and imbibe disposable delivery instrumentation, which provides spine and orthopedic surgeons with a method for harvesting a patients own bone marrow; Cortoss Bone Augmentation Material, a polymer composite for use in various surgical procedures to provide structural stability and reinforcement of the bones after surgery; and Aliquot Delivery System that facilitates delivery of materials to bony sites, including delivery of Cortoss product directly to the surgical site. The companys biosugery products include Vitagel surgical hemostat, a composite liquid hemostat that combines the biomaterials bovine thrombin and bovine collagen with the patients autologous plasma, and applied in the spine, hip, and knee replacement surgeries; and Vitasure Absorbable Hemostat, a plant-based hemostat product that can be deployed throughout surgery. It sells its products in the United States and internationally through a network of direct sales representatives and independent non-stocking distributors. The company has strategic partnerships with Kensey Nash Corporation; Angiotech Pharmaceuticals (U.S.), Inc.; and Medafor, Inc. Orthovita was founded in 1992 and is headquartered in Malvern, Pennsylvania.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net